271134 Impact of an Innovative HRA-based Wellness & Prevention Demonstration on HRA outcomes, Medicare Utilization and Costs

Wednesday, October 31, 2012 : 1:06 PM - 1:18 PM

Daver Kahvecioglu, PhD , Health Care Policy Research, IMPAQ International, Washington, DC
Betty Fout, PhD , Health Care Policy Research, IMPAQ International, Washington, DC
Katherine Kahn, MD , RAND Corporation, RAND Corporation, Santa Monica, CA
Research has suggested that risk reduction programs can encourage and help sustain the types of behavioral change that may prevent future health problems. In the Senior Risk Reduction Demonstration (SRRD), Medicare partnered with vendors to implement risk reduction programs for a sample of Medicare beneficiaries. The programs are comprised of health questionnaires, tailored health reports, customized educational materials, health counseling, self-management tools and referrals to national and local community resources. Based on the results of each participant's Health Risk Assessment (HRA), beneficiaries were randomly assigned to one of several treatment arms, which differed in the intensity of the intervention.

The first year of data of this three year intervention have been collected. We used a regression framework to test differences between treatment and controls groups for various Medicare claims and HRA variables. Key findings from this interim evaluation include: for one vendor, participants in the high-intensity treatment arm had $958 lower Medicare expenditures, 14.2% lower probability to be hospitalized and 0.3 fewer days of hospital stay than participants in a treatment arm who simply took an HRA without receiving tailored follow-up. For the other vendor, participants in the low-intensity treatment arm had $822 and $273 higher total and physician Medicare expenditures, respectively. We test the robustness of results using alternative estimators – difference in mean (DIM) and a difference-in-difference (DID). Additional years of data will be used to conduct the final analyses, but these interim results are informative to policymakers given the focus on prevention and wellness under the ACA.

Learning Areas:
Public health or related public policy
Public health or related research
Social and behavioral sciences

Learning Objectives:
1. Assess the interim impact of a randomized controlled trial using alternative estimators including linear regression and difference-in-difference after the first year of a three-year demonstration. 2. Compare the Medicare utilizations, costs and health risk assessment outcomes between a treatment group receiving a health risk assessment and follow-up risk reduction services and a control group receiving only a health risk assessment after the first year of a three-year demonstration.

Keywords: Prevention, Medicare

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a health and labor economist with expertise in program evaluation, analytical methods and policy analysis. I have led technical efforts in a number of projects for the Centers for Medicaid & Medicare Services (CMS), the Agency for Healthcare Research and Quality (AHRQ), the Administration on Aging (AoA), and the Department of Labor that involved experimental, quasi-experimental, and qualitative program evaluation, work process analysis, organizational analysis, and design and conduct of interviews.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.